HN2010000128A - Imidazoles sustituidos con heterociclilamida - Google Patents

Imidazoles sustituidos con heterociclilamida

Info

Publication number
HN2010000128A
HN2010000128A HN2010000128A HN2010000128A HN2010000128A HN 2010000128 A HN2010000128 A HN 2010000128A HN 2010000128 A HN2010000128 A HN 2010000128A HN 2010000128 A HN2010000128 A HN 2010000128A HN 2010000128 A HN2010000128 A HN 2010000128A
Authority
HN
Honduras
Prior art keywords
heterociclilamide
imidazols
replaced
prifilaxis
citomegalovirus
Prior art date
Application number
HN2010000128A
Other languages
English (en)
Inventor
Zimmermann Dr Holger
Bruckner Dr David
Henninger Dr Kerstin
Rosentreter Dr Ulrich
Hendrix Martin
Keldenich Jorg
Lang Dieter
Radtke Martin
Paulsen Daniela
Kern Armin
Original Assignee
Aicuris Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36675125&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN2010000128(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aicuris Gmbh & Co Kg filed Critical Aicuris Gmbh & Co Kg
Publication of HN2010000128A publication Critical patent/HN2010000128A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

SE REFIERE A IMIDAZOLES SUSTITUIDOS CON HETEROCICLILAMIDA Y PROCEDIMIENTOS PARA SU PREPARACION SU USO PARA EL TRATAMIENTO Y/O LA PRIFILAXIS DE ENFERMEDADES, ESPECIALMENTE PARA EL USO COMO AGENTES ANTIVIRALES ESPECIALMENTE CONTRA CITOMEGALOVIRUS
HN2010000128A 2005-02-23 2010-01-18 Imidazoles sustituidos con heterociclilamida HN2010000128A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005008183A DE102005008183A1 (de) 2005-02-23 2005-02-23 Heterocyclylamid-substituierte Imidazole

Publications (1)

Publication Number Publication Date
HN2010000128A true HN2010000128A (es) 2010-03-29

Family

ID=36675125

Family Applications (2)

Application Number Title Priority Date Filing Date
HN2006007774A HN2006007774A (es) 2005-02-23 2006-02-21 Imidazoles sustituidos con heterociclilamida
HN2010000128A HN2010000128A (es) 2005-02-23 2010-01-18 Imidazoles sustituidos con heterociclilamida

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HN2006007774A HN2006007774A (es) 2005-02-23 2006-02-21 Imidazoles sustituidos con heterociclilamida

Country Status (29)

Country Link
US (1) US7919489B2 (es)
EP (1) EP1853582B1 (es)
JP (1) JP5208522B2 (es)
KR (1) KR101276003B1 (es)
CN (1) CN101128455B (es)
AR (1) AR053141A1 (es)
AT (1) ATE446292T1 (es)
AU (1) AU2006218276C1 (es)
BR (1) BRPI0607995B8 (es)
CA (1) CA2598521C (es)
DE (2) DE102005008183A1 (es)
DK (1) DK1853582T3 (es)
ES (1) ES2333249T3 (es)
GT (1) GT200600077A (es)
HK (1) HK1110857A1 (es)
HN (2) HN2006007774A (es)
IL (1) IL185050A (es)
MX (1) MX2007010308A (es)
MY (1) MY140543A (es)
NO (1) NO338997B1 (es)
NZ (1) NZ560811A (es)
PE (2) PE20100233A1 (es)
PL (1) PL1853582T3 (es)
PT (1) PT1853582E (es)
RU (1) RU2415851C2 (es)
TW (1) TWI388553B (es)
UY (1) UY29387A1 (es)
WO (1) WO2006089664A2 (es)
ZA (1) ZA200707412B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004015007A1 (de) 2004-03-26 2005-10-13 Bayer Healthcare Ag Substituierte Imidazole
DE102005008183A1 (de) 2005-02-23 2006-08-31 Bayer Healthcare Ag Heterocyclylamid-substituierte Imidazole
DE102011101446A1 (de) * 2011-05-10 2012-11-15 Aicuris Gmbh & Co. Kg Herstellung von "Dense Bodies" (DB)
DE102011113749A1 (de) 2011-09-14 2013-03-14 Aicuris Gmbh & Co. Kg Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole
CN104610160A (zh) * 2013-11-04 2015-05-13 南京大学 含哌嗪环的5-硝基咪唑类衍生物及其制备与在抗菌药物中的应用
CN104016925B (zh) * 2014-06-17 2016-03-30 遵义医学院 4-烷基咪唑-2-羧酸的合成方法
CA2990583A1 (en) 2015-06-22 2016-12-29 Sumitomo Dainippon Pharma Co., Ltd. 1,4-disubstituted imidazole derivative
JP6507976B2 (ja) * 2015-09-30 2019-05-08 東レ株式会社 イミダゾール−２−カルボン酸エステル誘導体又はその塩の製造方法
CN116120238B (zh) * 2023-03-01 2023-09-22 山东梅奥华卫科技有限公司 一种咪唑衍生物的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342501B1 (en) 1994-02-25 2002-01-29 The Regents Of The University Of Michigan Pyrrolo[2,3-d] pyrimidines as antiviral agents
DE1019040T1 (de) * 1997-05-23 2001-02-08 Bayer Ag Hemmung von p38 kinase aktivität durch arylharnstoff
US6080763A (en) 1997-11-03 2000-06-27 Boehringer Ingelheim Pharmaceuticals, Inc. Aromatic heterocyclic compounds and their use as anti-inflammatory agents
EA200100639A1 (ru) 1998-12-09 2002-06-27 Американ Хоум Продактс Корпорейшн Производные тиомочевины, содержащие гетероциклический карбоксамид и защитную группу фенилэтиленамина, в качестве ингибиторов вирусов герпеса
DE10257358A1 (de) 2002-12-09 2004-07-08 Bayer Healthcare Ag Substituierte Pyrrole
DE102004015007A1 (de) 2004-03-26 2005-10-13 Bayer Healthcare Ag Substituierte Imidazole
CA2565519A1 (en) * 2004-05-12 2005-12-01 Schering Corporation Cxcr1 and cxcr2 chemokine antagonists
DE102005008183A1 (de) 2005-02-23 2006-08-31 Bayer Healthcare Ag Heterocyclylamid-substituierte Imidazole

Also Published As

Publication number Publication date
EP1853582B1 (de) 2009-10-21
ZA200707412B (en) 2008-12-31
PL1853582T3 (pl) 2010-03-31
DE502006005182D1 (de) 2009-12-03
HK1110857A1 (en) 2008-07-25
NO338997B1 (no) 2016-11-07
JP2008531508A (ja) 2008-08-14
JP5208522B2 (ja) 2013-06-12
PE20100233A1 (es) 2010-04-22
RU2007135277A (ru) 2009-03-27
GT200600077A (es) 2006-10-03
BRPI0607995A2 (pt) 2009-10-27
IL185050A0 (en) 2007-12-03
US7919489B2 (en) 2011-04-05
WO2006089664A3 (de) 2006-11-02
BRPI0607995B1 (pt) 2019-07-16
CN101128455B (zh) 2013-01-16
US20080176859A1 (en) 2008-07-24
MY140543A (en) 2009-12-31
TW200700411A (en) 2007-01-01
IL185050A (en) 2013-01-31
KR20080002772A (ko) 2008-01-04
ATE446292T1 (de) 2009-11-15
MX2007010308A (es) 2007-10-17
NZ560811A (en) 2010-07-30
EP1853582A2 (de) 2007-11-14
AU2006218276B2 (en) 2011-04-07
RU2415851C2 (ru) 2011-04-10
PT1853582E (pt) 2009-11-13
KR101276003B1 (ko) 2013-06-20
TWI388553B (zh) 2013-03-11
CA2598521C (en) 2012-11-27
CN101128455A (zh) 2008-02-20
AU2006218276A1 (en) 2006-08-31
ES2333249T3 (es) 2010-02-18
DK1853582T3 (da) 2010-01-18
WO2006089664A2 (de) 2006-08-31
AR053141A1 (es) 2007-04-25
NO20074780L (no) 2007-11-01
AU2006218276C1 (en) 2012-06-28
BRPI0607995B8 (pt) 2021-05-25
PE20061141A1 (es) 2006-12-29
UY29387A1 (es) 2006-10-02
HN2006007774A (es) 2010-03-29
DE102005008183A1 (de) 2006-08-31
CA2598521A1 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
HN2010000128A (es) Imidazoles sustituidos con heterociclilamida
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
GT200800250A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
DOP2012000299A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
UY31228A1 (es) Ariloxazoles sustituidos y su uso
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
ECSP12011943A (es) Antagonistas de espiro-oxindol de mdm2
CL2009001099A1 (es) Uso de una muteina de interleuquina-2 humana para el tratamiento y/o prevencion de una enfermedad autoinmune.
GT201000008A (es) Agentes citotoxicos que comprenden nuevos derivados de tomaimicina y su uso terapeutico
ECSP109923A (es) Bromhidrato de bupropion y aplicaciones terapéuticas
PA8657801A1 (es) Aminalcoholes triciclicos, procedimientos para su preparacion
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
CL2013000735A1 (es) Uso de una composicion que comprende compuestos derivados de 1-h-imidazol-4-il sustituido para el tratamiento de enfermedades y condiciones de la piel, tales como rosacea, daño solar cronico, psoriasis, entre otras; kit farmaceutico.
UY31133A1 (es) "oxazolidinonas sustituidas y su uso"
AR053775A1 (es) Nonadepsipeptidos acilados ii
UY29417A1 (es) Agentes endoparasiticidas
CL2012001757A1 (es) Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica; y su uso en el tratamiento de infecciones micoticas.
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
UY31717A1 (es) (pirazolilcarbonil) imidazolidinonas sustituidas y su uso
GT200600153A (es) Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como antiinflamatorios.
CR11340A (es) Mezclas fungicidas de triticonazol y difenoconazol
CR20120112A (es) Formulaciones y metodos que emplean desinfectante anhidro
ATE437624T1 (de) Topische zusammensetzungen